- Home
- JYNT vs PRME Comparison
JYNT vs PRME Comparison
Compare JYNT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- PRME
- Stock Information
- Founded
- JYNT 2010
- PRME 2019
- Country
- JYNT United States
- PRME United States
- Employees
- JYNT N/A
- PRME N/A
- Industry
- JYNT Multi-Sector Companies
- PRME Medicinal Chemicals and Botanical Products
- Sector
- JYNT Miscellaneous
- PRME Health Care
- Exchange
- JYNT Nasdaq
- PRME Nasdaq
- Market Cap
- JYNT 170.1M
- PRME 191.7M
- IPO Year
- JYNT 2014
- PRME 2022
- Fundamental
- Price
- JYNT $11.52
- PRME $2.07
- Analyst Decision
- JYNT Strong Buy
- PRME Buy
- Analyst Count
- JYNT 2
- PRME 6
- Target Price
- JYNT $15.50
- PRME $9.38
- AVG Volume (30 Days)
- JYNT 65.4K
- PRME 2.3M
- Earning Date
- JYNT 08-07-2025
- PRME 08-04-2025
- Dividend Yield
- JYNT N/A
- PRME N/A
- EPS Growth
- JYNT N/A
- PRME N/A
- EPS
- JYNT N/A
- PRME N/A
- Revenue
- JYNT $52,789,479.00
- PRME $3,846,000.00
- Revenue This Year
- JYNT $9.72
- PRME $104.12
- Revenue Next Year
- JYNT $10.92
- PRME $196.78
- P/E Ratio
- JYNT N/A
- PRME N/A
- Revenue Growth
- JYNT 71.05
- PRME 550.76
- 52 Week Low
- JYNT $9.58
- PRME $1.11
- 52 Week High
- JYNT $15.32
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- JYNT 53.47
- PRME 71.75
- Support Level
- JYNT $11.48
- PRME $1.56
- Resistance Level
- JYNT $12.49
- PRME $1.85
- Average True Range (ATR)
- JYNT 0.86
- PRME 0.19
- MACD
- JYNT -0.04
- PRME 0.07
- Stochastic Oscillator
- JYNT 42.66
- PRME 96.74
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.